299 related articles for article (PubMed ID: 30063383)
1. MRI guided stereotactic radiotherapy for locally advanced pancreatic cancer.
Heerkens HD; van Vulpen M; Erickson B; Reerink O; Intven MP; van den Berg CA; Molenaar IQ; Vleggaar FP; Meijer GJ
Br J Radiol; 2018 Nov; 91(1091):20170563. PubMed ID: 30063383
[TBL] [Abstract][Full Text] [Related]
2. Linac-based stereotactic body radiation therapy for unresectable locally advanced pancreatic cancer: risk-adapted dose prescription and image-guided delivery.
Mazzola R; Fersino S; Aiello D; Gregucci F; Tebano U; Corradini S; Di Paola G; Cirillo M; Tondulli L; Ruffo G; Ruggieri R; Alongi F
Strahlenther Onkol; 2018 Sep; 194(9):835-842. PubMed ID: 29696321
[TBL] [Abstract][Full Text] [Related]
3. Pancreatic cancer treated with SBRT: Effect of anatomical interfraction variations on dose to organs at risk.
Loi M; Magallon-Baro A; Suker M; van Eijck C; Sharma A; Hoogeman M; Nuyttens J
Radiother Oncol; 2019 May; 134():67-73. PubMed ID: 31005226
[TBL] [Abstract][Full Text] [Related]
4. Simulated Online Adaptive Magnetic Resonance-Guided Stereotactic Body Radiation Therapy for the Treatment of Oligometastatic Disease of the Abdomen and Central Thorax: Characterization of Potential Advantages.
Henke L; Kashani R; Yang D; Zhao T; Green O; Olsen L; Rodriguez V; Wooten HO; Li HH; Hu Y; Bradley J; Robinson C; Parikh P; Michalski J; Mutic S; Olsen JR
Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):1078-1086. PubMed ID: 27742541
[TBL] [Abstract][Full Text] [Related]
5. Dosimetric analysis of stereotactic rotational versus static intensity-modulated radiation therapy for pancreatic cancer.
Cho I; Park JW; Cho B; Kwak J; Yoon SM; Nesseler JP; Park J; Kim JH
Cancer Radiother; 2018 Dec; 22(8):754-762. PubMed ID: 30322818
[TBL] [Abstract][Full Text] [Related]
6. Feasibility of delivered dose reconstruction for MR-guided SBRT of pancreatic tumors with fast, real-time 3D cine MRI.
Grimbergen G; Pötgens GG; Eijkelenkamp H; Raaymakers BW; Intven MPW; Meijer GJ
Radiother Oncol; 2023 May; 182():109506. PubMed ID: 36736589
[TBL] [Abstract][Full Text] [Related]
7. Dosimetric impact of intrafraction motion under abdominal compression during MR-guided SBRT for (Peri-) pancreatic tumors.
Grimbergen G; Eijkelenkamp H; Heerkens HD; Raaymakers BW; Intven MPW; Meijer GJ
Phys Med Biol; 2022 Sep; 67(18):. PubMed ID: 36041431
[No Abstract] [Full Text] [Related]
8. EUS-guided fiducial placement for stereotactic body radiotherapy in locally advanced and recurrent pancreatic cancer.
Sanders MK; Moser AJ; Khalid A; Fasanella KE; Zeh HJ; Burton S; McGrath K
Gastrointest Endosc; 2010 Jun; 71(7):1178-84. PubMed ID: 20362284
[TBL] [Abstract][Full Text] [Related]
9. Dosimetric Benefits and Practical Pitfalls of Daily Online Adaptive MRI-Guided Stereotactic Radiation Therapy for Pancreatic Cancer.
El-Bared N; Portelance L; Spieler BO; Kwon D; Padgett KR; Brown KM; Mellon EA
Pract Radiat Oncol; 2019 Jan; 9(1):e46-e54. PubMed ID: 30149192
[TBL] [Abstract][Full Text] [Related]
10. Initial clinical observations of intra- and interfractional motion variation in MR-guided lung SBRT.
Thomas DH; Santhanam A; Kishan AU; Cao M; Lamb J; Min Y; O'Connell D; Yang Y; Agazaryan N; Lee P; Low D
Br J Radiol; 2018 Feb; 91(1083):20170522. PubMed ID: 29166129
[TBL] [Abstract][Full Text] [Related]
11. Intrafraction Motion Management of Renal Cell Carcinoma With Magnetic Resonance Imaging-Guided Stereotactic Body Radiation Therapy.
Prins FM; Stemkens B; Kerkmeijer LGW; Barendrecht MM; de Boer HJ; Vonken EPA; Lagendijk JJW; Tijssen RHN
Pract Radiat Oncol; 2019 Jan; 9(1):e55-e61. PubMed ID: 30261329
[TBL] [Abstract][Full Text] [Related]
12. Technical feasibility and clinical evaluation of 4D-MRI guided liver SBRT on the MR-linac.
van de Lindt TN; Nowee ME; Janssen T; Schneider C; Remeijer P; van Pelt VWJ; Betgen A; Jansen EPM; Sonke JJ
Radiother Oncol; 2022 Feb; 167():285-291. PubMed ID: 35033603
[TBL] [Abstract][Full Text] [Related]
13. The first reported case of a patient with pancreatic cancer treated with cone beam computed tomography-guided stereotactic adaptive radiotherapy (CT-STAR).
Kim M; Schiff JP; Price A; Laugeman E; Samson PP; Kim H; Badiyan SN; Henke LE
Radiat Oncol; 2022 Sep; 17(1):157. PubMed ID: 36100866
[TBL] [Abstract][Full Text] [Related]
14. Functional image-guided stereotactic body radiation therapy planning for patients with hepatocellular carcinoma.
Tsegmed U; Kimura T; Nakashima T; Nakamura Y; Higaki T; Imano N; Doi Y; Kenjo M; Ozawa S; Murakami Y; Awai K; Nagata Y
Med Dosim; 2017 Summer; 42(2):97-103. PubMed ID: 28433483
[TBL] [Abstract][Full Text] [Related]
15. Elective nodal irradiation with simultaneous integrated boost stereotactic body radiotherapy for pancreatic cancer: Analyses of planning feasibility and geometrically driven DVH prediction model.
Nakamura A; Prichard HA; Wo JY; Wolfgang JA; Hong TS
J Appl Clin Med Phys; 2019 Feb; 20(2):71-83. PubMed ID: 30636367
[TBL] [Abstract][Full Text] [Related]
16. Intrafractional relationship changes between an external breathing signal and fiducial marker positions in pancreatic cancer patients.
Pettersson N; Oderinde OM; Murphy J; Simpson D; Cerviño LI
J Appl Clin Med Phys; 2020 Mar; 21(3):153-161. PubMed ID: 32170900
[TBL] [Abstract][Full Text] [Related]
17. Retrospective evaluation of decision-making for pancreatic stereotactic MR-guided adaptive radiotherapy.
Tyran M; Jiang N; Cao M; Raldow A; Lamb JM; Low D; Luterstein E; Steinberg ML; Lee P
Radiother Oncol; 2018 Nov; 129(2):319-325. PubMed ID: 30174107
[TBL] [Abstract][Full Text] [Related]
18. Potential dosimetric benefits of adaptive tumor tracking over the internal target volume concept for stereotactic body radiation therapy of pancreatic cancer.
Karava K; Ehrbar S; Riesterer O; Roesch J; Glatz S; Klöck S; Guckenberger M; Tanadini-Lang S
Radiat Oncol; 2017 Nov; 12(1):175. PubMed ID: 29121945
[TBL] [Abstract][Full Text] [Related]
19. Simulated computed tomography-guided stereotactic adaptive radiotherapy (CT-STAR) for the treatment of locally advanced pancreatic cancer.
Schiff JP; Price AT; Stowe HB; Laugeman E; Chin RI; Hatscher C; Pryser E; Cai B; Hugo GD; Kim H; Badiyan SN; Robinson CG; Henke LE
Radiother Oncol; 2022 Oct; 175():144-151. PubMed ID: 36063981
[TBL] [Abstract][Full Text] [Related]
20. Tumor motion changes in stereotactic body radiotherapy for liver tumors: an evaluation based on four-dimensional cone-beam computed tomography and fiducial markers.
Shimohigashi Y; Toya R; Saito T; Ikeda O; Maruyama M; Yonemura K; Nakaguchi Y; Kai Y; Yamashita Y; Oya N; Araki F
Radiat Oncol; 2017 Mar; 12(1):61. PubMed ID: 28335794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
